Shanghai Pharma Mingde New Drug R&D

WuXi AppTec is a leading global provider of R&D and manufacturing services that enable the pharmaceutical and biotech industries to advance discoveries and deliver groundbreaking treatments. Operating as an open-access platform, the company offers a comprehensive suite of services through its business units, including WuXi Chemistry, WuXi Biology, WuXi Testing, and WuXi Advanced Therapies (ATU). Its Shanghai-based subsidiary, Shanghai Mingde New Drug Development Co., Ltd., serves as a core hub for its integrated drug discovery and development operations. WuXi AppTec's unique CRDMO and CTDMO models provide end-to-end solutions from early-stage research to commercial manufacturing across multiple therapeutic modalities.